Ledger.Open graph →
SEC Form D · filed October 23, 2013

ARATANA THERAPEUTICS, INC

Offering
$29.8M
Sold
$29.8M
Exemption
Rule 506(b)
Industry
Pharmaceuticals
Location
KANSAS CITY, KS
Type

Rule 506(b): private placement to accredited investors, no public advertising.

People & firms on this filing (12)

Robert Gerber · Boca Raton, FLDirectorCraig Tooman · Kansas City, KSDirectorJay Lichter, Ph.D · La Jolla, CAExec · DirectorRobert Gerber · CARLSBAD, CADirectorRonald L. Meeusen, Ph.D · Burr Ridge, ILDirectorCraig Tooman · London, United KingdomDirectorJohn Vander Vort · Kansas City, KSDirectorSteven St. Peter, M.D · Kansas City, KSExec · DirectorLinda Rhodes, V.M.D., Ph.D · Kansas City, KSExec · DirectorLouise A. Mawhinney · New Haven, CTExecErnst Heinen, D.V.M., Ph.D · Kansas City, KSExecJulia A. Stephanus · Kansas City, KSExec

Public SEC Form D (Reg D) filing. · View issuer on SEC EDGAR ↗